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Molecular chaperones, or heat shock proteins (HSPs), protect against the toxic
misfolding and aggregation of proteins. As such, mutations or deﬁciencies
within the chaperone network can lead to disease. Dominant mutations within
DNAJB6 (Hsp40)—an Hsp70 co-chaperone—lead to a protein aggregationlinked myopathy termed Limb-Girdle Muscular Dystrophy Type D1 (LGMDD1).
Here, we used the yeast prion model client in conjunction with in vitro chaperone activity assays to gain mechanistic insights into the molecular basis of
LGMDD1. Here, we show how mutations analogous to those found in LGMDD1
affect Sis1 (a functional homolog of human DNAJB6) function by altering the
structure of client protein aggregates, interfering with the Hsp70 ATPase
cycle, dimerization and substrate processing; poisoning the function of wildtype protein. These results uncover the mechanisms through which LGMDD1associated mutations alter chaperone activity, and provide insights relevant to
potential therapeutic interventions.

Limb-girdle muscular dystrophies (LGMDs) are a genetically heterogeneous family of muscle disorders that are either autosomal dominant or recessive1. Although most recessive LGMDs are characterized
by a loss-of-function, the mechanistic nature of dominantly inherited
LGMDs is unclear. These late onset degenerative myopathies are uniﬁed by similar myopathologies that include myoﬁbrillar disorganization, impaired protein degradation, and the accumulation of protein
inclusions that contain structural muscle proteins such as desmin and
α-actinin and RNA binding proteins such as TDP-432–4. This toxic misfolding and aggregation of proteins is protected by the activity of
molecular chaperones, or heat shock proteins (HSPs). As such,

mutations in these chaperones can lead to diseases termed “chaperonopathies”. One such example is Limb-Girdle Muscular Dystrophy
Type D1 (LGMDD1), caused by mutations in DNAJB6 (Hsp40), an Hsp70
co-chaperone4. The originally identiﬁed LGMDD1 disease mutations
are present within the 12 amino acid stretch of the glycine/phenylanine
(G/F) rich domain3–7. DNAJB6 is expressed ubiquitously and participates in protein folding and disaggregation8–11; however, its role in
skeletal muscle protein homeostasis is unknown. In addition, DNAJB6
client proteins and DNAJB6 chaperone interactions in skeletal muscle
are not known. Fortunately, DNAJB clients are well-characterized in
yeast and thereby afford a model system to study the effect of disease-
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causing mutants. Moreover, the understanding of DNAJB function
within the yeast chaperone network is more complete than in skeletal
muscle. Previously, we utilized a transdisciplinary approach to ascertain the functionality of LGMDD1-associated mutants in model
systems12. Here, we generated homologous DNAJB6 LGMDD1 G/F
domain mutations in the essential yeast DNAJ protein Sis1 (DNAJB6F93L (Sis1-F106L), DNAJB6-N95L (Sis1-N108L), DNAJB6-D98Δ (Sis1D110Δ), and DNAJB6-F100I (Sis1-F115I)). Our goal is to accelerate our
understanding of mutant DNAJB6 dysfunction in LGMDD1 and thus
facilitate therapeutic target identiﬁcation as well as to gain insight into
the relationship between protein quality control and myopathy.
The Hsp70/DNAJ machinery is vital to the protein quality control
network. The Hsp70 machine works in an ATP-dependent manner to
act on client proteins through a cycle of regulated binding and
release13. Client speciﬁcity of the Hsp70 machine is modulated by
DNAJ proteins (Hsp40s). By dictating client speciﬁcity, DNAJ proteins
have been described as the primary facilitators of the cellular protein
quality control system and play a pivotal role in determining the fate
of a misfolded protein—whether is refolded or degraded13. A variety
of disease-associated misfolded proteins have been shown to interact or colocalize with DNAJ family members8,14. These effects are
generally, although not exclusively, dependent upon cooperation
with Hsp708,13. Strikingly, previous work from our lab suggests that
the LGMDD1 mutants not only show substrate speciﬁcity, but also
show conformation-speciﬁc effects12,15. These results were obtained
through analysis of LGMDD1 mutants in the DNAJ protein Sis1, which
has well-known yeast prion protein clients. Unlike mammalian
prions, yeast prions are non-toxic, but phenotypic and biochemical
assays enable rapid detection of [PRION+] cells16. Yeast chaperones
Hsp104, Hsp70 (Ssa1), and the Hsp40 (Sis1) regulate prion propagation by acting on prion protein aggregates17. Alterations in chaperone level or function result in a failure to promote prion
propagation18,19.
One of the most interesting features of prions is the existence of
prion strains. Prion strains are distinct self-propagating protein
aggregate structures that cause changes in transmissibility and disease
pathology with the same aggregating protein20. Yeast prion strains
differ from each other based on phenotype, the ratio of soluble to
aggregated protein, and their ability to propagate the prion20. Previously, we found that homologous LGMDD1 mutations in Sis1 appear
to reduce functionality, as determined by changes in their ability to
modulate the aggregated state of select yeast prion strains12. We then
assessed the effect of these mutants in mammalian systems, including
mouse models, and LGMDD1 patient ﬁbroblasts, where we analyzed
the aggregation of TDP-43, an RNA binding protein with a prion-like
domain that is a marker of degenerative disease including LGMDD1.
DNAJB6 mutant expression enhanced the aggregation and impaired
the dissolution of nuclear stress granules containing TDP-43 following
heat shock12. Recently, three novel pathogenic mutations associated
with LGMDD1 have been identiﬁed within the J domain of DNAJB621.
Interestingly, we found that homologous mutations in the Sis1 J
domain differentially alter the processing of speciﬁc yeast prion
strains, as well as a non-prion substrate15.
Here, we used the yeast prion model system, and in vitro chaperone activity assays to determine how LGMDD1 homologous missense mutations in the Sis1 G/F domain alter chaperone function with
and without Hsp70. We found that LGMDD1 mutants inhibit the Hsp70
ATPase cycle function in a client-conformer-speciﬁc manner. Moreover, both prion propagation and luciferase refolding activity were
enhanced in mutant strains by either deleting the NEF (Sse1) or by
using an Sse1-mutant, indicating that ﬁne-tuning of substrate processing can rescue the mutant defects. To our knowledge, this is the ﬁrst
mechanistic insight describing the effect of LGMDD1 mutants on
Hsp70/40 ATPase cycle. Additionally, these results suggest that the
development of a titrated approach using speciﬁc inhibitors of the
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Hsp70/DNAJ cycle is a potential therapeutic strategy for this class of
myopathy-associated chaperonopathies.

Results
LGMDD1-associated homologous G/F domain mutants in Sis1
have variable substrate processing efﬁciency
In previous studies, we analyzed the functionality of LGMDD1
mutants in Sis1 using two yeast prion proteins that require Sis1 for
propagation: Rnq1 (which forms the [RNQ+] prion) and Sup35 (which
forms the [PSI+] prion). We found that LGMDD1 mutants had
conformer-speciﬁc processing defects, in that they promoted the
propagation of some prion strains but not all12. This suggests that the
mutant chaperones may recognize their normal clients in some
conformations but not others. Alternatively, the mutant chaperones
may recognize clients but not be able to effectively process the
misfolded protein. Hsp40 client processing for refolding requires
multiple steps: binding, dimerization, binding to Hsp70, and
nucleotide exchange-stimulated client release. We evaluated the
function of LGMDD1 mutants as compared to wild type (WT), by
purifying these proteins (Supplementary Fig. 1) and using them in
assays that address these steps.
One way to determine substrate processing of a chaperone that
interacts with amyloidogenic proteins is to evaluate the kinetics of
aggregation of client proteins in vitro. We assessed amyloid formation
of Rnq1 in the presence of Sis1-WT and LGMDD1 mutants (G/F domain
mutants Sis1-F106L, Sis1-N108L, Sis1-D110Δ and, Sis1-F115I). Rnq1 is a
well-known substrate of Sis122 and has been reported to form higherorder aggregates in vitro23. Aggregation of Rnq1 was monitored by the
enhanced ﬂuorescence emission of the dye Thioﬂavin T (ThT), which is
used as a marker for cross β sheet conformation of amyloid ﬁbrils24.
During the initial phase of incubation (lag phase), natively disordered
protein monomer did not show any change in ﬂuorescence intensity of
ThT (Fig. 1a). This was followed by an increase in ThT ﬂuorescence
intensity, indicative of the formation of ﬁbrils. Finally, the ﬂuorescence
intensity of the dye achieved a plateau (stationary phase). The lag
phase was increased in the presence of Sis1-WT as compared to Rnq1
without chaperone (Fig. 1a), indicating that the time required for
productive nucleation of unseeded Rnq1 was longer in the presence of
chaperone. However, the lag phase of Rnq1 ﬁber formation was shorter
with LGMDD1 mutants than Sis1-WT but longer than that of Rnq1 alone
(Fig. 1a). The overall ﬁbril formation rate was also higher in the presence of the mutants as compared to Sis1-WT (Fig. 1a). The time to 50%
ThT is shown in the inset (Fig. 1a). We also performed seeded kinetic
assays with Rnq1 ﬁbers formed at 18, 25, and 37 °C. We found that ﬁber
elongation was faster (in the absence of chaperone) with seeded Rnq1
at 18 °C, than at 25 °C or 37 °C (Supplementary Fig. 2a–c). Similarly, in
the presence of Sis1-WT, the difference in ﬁber elongation using
Rnq1 seeds formed at the three temperatures was negligible (Supplementary Fig. 2d–f). This suggests that the primary impact of Sis1 on
Rnq1 ﬁber formation is in the formation of amyloid-competent conformers (nucleation).
We then hypothesized that, if the primary chaperone effect is to
alter the nucleation of the amyloidogenic protein, the ﬁbers formed
with and without chaperone could be structurally distinct. As such, we
assessed the morphology of Rnq1 ﬁbrils formed at 18 °C with and
without chaperone by transmission electron microscopy (TEM). TEM
images show that Rnq1 forms long, elongated, branched ﬁbrils in the
absence of chaperone (Fig. 1b). By contrast, Rnq1 ﬁbers formed in the
presence of Sis1-WT were short and appeared immature or perhaps
bound to chaperone (Fig. 1b). This suggests that Sis1-WT might only
delay ﬁbril formation rather than preventing it. In the presence of
LGMDD1 mutant (Sis1-F115I), very few ﬁbers were visible (Fig. 1b), and
they were mostly distorted and appeared to be small oligomeric species. Taken together with our ThT ﬁndings, these data suggest that
different ThT binding sites are present within these morphologically
2
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distinct Rnq1 aggregates. Additionally, these data suggest that the
interaction of LGMDD1 mutants with client alter client conformation in
a manner that is distinct from that of wildtype chaperone.
While the interaction with prion substrate showed that LGMDD1
mutants alter amyloid formation, DNAJ proteins typically act in
conjunction with Hsp70 to process substrates. We then asked
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whether the LGMDD1 mutants could promote substrate refolding in
the presence of co-chaperones. Previously Aron et al. showed that
Sis1 lacking the G/F domain (Sis1ΔG/F) is defective in chaperone
activity and partially inhibits the ability of Sis1-WT to facilitate folding
of denatured luciferase protein25. Therefore, to test the ability of
LGMDD1 mutants to function in substrate refolding, we heat3

Article
Fig. 1 | LGMDD1 G/F domain mutants show variability in substrate processing.
a Kinetics of Rnq1 ﬁbrillation in the presence of unseeded Rnq1 only (cyan blue),
Sis1-WT (black), Sis1-F106L (yellow), Sis1-N108L (red), Sis1-D110Δ (green), or Sis1F115I (blue) measured by ThT ﬂuorescence assay. Inset: - Time to 50% ThT ﬂuorescence was calculated by ﬁtting the graph using the EC50 (Y = Bottom + (TopBottom)/(1 + 10^((lnEC50-X)*HillSlope)) equation in Graph pad prism. RFU is Relative ﬂuorescence unit. Values shown are mean ± SEM, n = 3 biologically independent samples. For (a; inset) each LGMDD1 mutant was compared with Sis1-WT
across and ***p < 0.00019 for Sis1-F115I, **p < 0.00446 for Sis1-N108L, *p < 0.0489
for Sis1-F106L, NS = 0.25297 (non-signiﬁcant) for Sis1-D110Δ values are reported for
unpaired, two-sided t-test. b The morphology of amyloid ﬁbers formed from Rnq1

https://doi.org/10.1038/s41467-022-32318-9
at 18 °C in vitro in the presence and absence of Sis1-WT and/or LGMDD1 mutant
were imaged by TEM. Experiments were performed in triplicate, representative
images shown. The scale bar represents 200 nm. c Refolding activity of heatdenatured luciferase in the presence of LGMDD1 mutants. Luciferase along with
Ssa1-WT and Sis1-WT/mutants was incubated at 42 °C for 10 min to heat denature
luciferase. At various time points, activity was measured by a luminometer after
adding substrate. Values shown are mean + SEM, n = 3 biologically independent
samples. For c; each LGMDD1 mutant was compared with Sis1-WT across all timepoints and ***p < 0.001, **p < 0.01, and *p < 0.05 values are reported for unpaired,
two-sided t-test. Source data are provided as a Source data ﬁle.

denatured ﬁreﬂy luciferase and then monitored refolding in the
presence or absence of chaperones. We found that the LGMDD1
mutants were all compromised in their ability to refold luciferase
(Fig. 1c, see also controls Supplementary Fig. 2g). Taken together,
these results indicate that the LGMDD1 mutants are defective in
substrate processing.

LGMDD1-associated G/F domain mutants change the formation
of in vitro formed [RNQ+] prion strains

Fig. 2 | Phenotypic distribution of [RNQ+] strain alters with LGMDD1 G/F
domain mutants. a Cartoon showing transformation of Rnq1 amyloid ﬁbers
formed at 18 °C into [prion-/rnq−] 74-D694 yeast cells induces strains of the
[PRION+/RNQ+] prion. RRP was used to assess [RNQ+] phenotype. [RNQ+] prion
strains co-aggregate with RRP and cause different phenotypes; colony color on
YPD and growth on SD-ade medium are indicative of different levels of suppression of the ade1-14 premature stop codon to produce Ade1 and represent
different [RNQ+] strains. Curability by growth and color on medium containing
GdnHCl was used to determine prion-dependence of phenotypes. The transformants from ﬁve separate experiments for each sample set were picked and >200
colonies for each set were scored as very weak, weak, medium, or strong [RNQ+]
b and graphed for statistical analysis c. In panel c, the blue color indicates the
comparison between Rnq1 (alone) and Rnq1 with Sis1-WT; NS = 0.197 for strong
[RNQ+], ***p < 0.00023 for medium [RNQ+], NS = 0.357 for weak [RNQ+],
***p < 0.00025 for very weak [RNQ+]. Black color indicates the comparison
between Sis1-WT and LGMDD1 mutants (F106L and F115I); (NS = 0.298 and 0.269)
for strong [RNQ+], (NS = 0.165 and **p < 0.008) for medium [RNQ+], (*p < 0.022
and **p < 0.008) for weak [RNQ+], (NS = 0.231 and 0.409) for very weak [RNQ+]. pvalues are reported for unpaired, two-sided t-test. Source data are provided as a
Source data ﬁle.
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Given the striking differences in ﬁbril formation kinetics and TEM
images, we wanted to determine whether LGMDD1 mutants alter the
formation of Rnq1 amyloid structures using a more sensitive and
quantitative method that is uniquely available in the yeast prion system. This entails infecting yeast with amyloid generated in vitro and
assessing the resulting [RNQ+] prion strains. Previously, we found that
amyloid ﬁbers of Rnq1PFD (prion-forming domain) formed at different
temperatures resulted in the generation of different prion strains26.
We hypothesized that Rnq1 amyloid structure, and resulting [RNQ
+] strain distribution, would differ in the presence of Sis1 and LGMDD1
mutants. We formed Rnq1 ﬁbers at 18 °C in the presence and absence
of Sis1-WT and two LGMDD1 mutants. We transformed ﬁbers formed in
the presence or absence of chaperone into cells expressing [RNQ+]
reporter protein (RRP) that did not have the prion ([rnq-]) (Fig. 2a and
Supplementary Fig. 3a). We developed and utilized this reporter strain
as a phenotypic indicator of [RNQ+] prion strain propagation26. Yeast
strains expressing the RRP reporter display different levels of ade1-14
nonsense suppression in [RNQ+] variants (Supplementary Fig. 3b). By
assessing colony color (white, light pink, or dark pink) as well as
growth on selective medium (SD-Ade), we scored [RNQ+] strains
(Fig. 2b and Supplementary Fig. 3b) that resulted after ﬁber infection.
Lighter colony color and more growth on SD-Ade medium was scored
as a stronger [RNQ+] strain, whereas darker colony color and less
growth on selective medium was scored as a weaker [RNQ+] strain (see
“Methods” for more information). [RNQ+] strains were also veriﬁed for
the prion-speciﬁc trait of curability on medium containing guanidine
hydrochloride (Fig. 2b). To quantify the difference in [RNQ+] strains
formed in the presence of LGMDD1 mutants, we counted the phenotype of infected colonies from ﬁve different transformation sets for
each sample (Fig. 2b). With Rnq1 alone, ~58% of cells showed very weak
[RNQ+] phenotypes. This fraction of very weak [RNQ+] was reduced to
less than 20% in the presence of Sis1-WT and was further reduced in the
presence of the LGMDD1 mutants. There was a signiﬁcant increase in
the medium [RNQ+] strain phenotype (44% +/− 4.5%) in the presence of
Sis1-WT as compared to Rnq1 alone (14% +/− 1.4%). When we compared
[RNQ+] strain distribution between Sis1-WT and LGMDD1 mutants, we
found that the proportion of weak Rnq1 strains was signiﬁcantly
increased with both F106L and F115I (~20% in Sis1-WT vs. 50% in F106L
and 65% in F115I). Similarly, the population of medium [RNQ+] strain
was signiﬁcantly decreased in F115I as compared to Sis1-WT (~20% in
F115I vs. 45% in Sis1-WT). The distribution of other [RNQ+] strains,
strong and very weak, with LGMDD1 mutants were similar to Sis1-WT.
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Fig. 3 | Stimulation of ATPase activity of Ssa1 by LGMDD1 G/F domain mutants
is client-conformation speciﬁc. Stimulation of Ssa1 ATPase activity in the presence of Rnq1 seeds formed at a 18 °C, b 25 °C, and c 37 °C. Ssa1 (1 µM) in complex
with ATP (1 mM) in the presence of Sis1-WT (black) or Sis1-mutants (Sis1-F106L
(yellow), Sis1-N108L (red), Sis1-D110Δ (green), or Sis1-F115I (blue)) (0.05 µM). The
fraction of ATP converted to ADP was determined. For a–c, a total of 10% seeds
were used in a reaction. In all cases, only Ssa1 with Rnq1 (orange), Sis1 with Ssa1

(dark purple) and were used as controls. For a–c, Sis1-WT was compared with
LGMDD1- mutants. Data are presented as mean values + SEM, n = 4 biologically
independent samples. For a (left to right); ***p < 1.29e−07, ***p < 6.29e−08,
***p < 4.78e−07, ***p < 2.41e−07; for b (left to right); ***p < 4.64e−05, ***p < 6.31e−05,
***p < 0.0001, ***p < 0.0001; and for c (left to right); **p < 0.004, ***p < 2.63e−05,
**p < 0.002, ***p < 9.59e−05. p-values are reported for unpaired, two-sided t-test.
Source data are provided as a Source data ﬁle.

Thus, the difference in distribution of [RNQ+] strains generated in the
presence of LGMDD1 mutants suggest that amyloid structures can be
altered by mutant chaperones.

LGMDD1 G/F domain mutants alters both substrate and Hsp70
binding

LGMDD1-associated homologous mutants in Sis1 (Hsp40) alters
its ability to function with Ssa1 (Hsp70) efﬁciently
Hsp40s target substrates to their Hsp70 partners and regulate the
ATPase activity and substrate binding of the Hsp7013. The recognition of substrates depends on their conformation, and it has been
suggested that much of the Hsp40 conformation-dependent recognition is dependent on the G/F domain22,27–29. Additionally, in our
previous work, we found client-conformer speciﬁc defects in vivo
with the LGMDD1 mutants12. Therefore, we asked whether the conformation of the client impacted the function of the mutants. We
measured the ability of Sis1-WT and LGMDD1 mutants to stimulate
the ATPase activity of Ssa1 in the presence and absence of different
Rnq1 protein conformers. We standardized the Rnq1 monomer
concentration and performed a phosphate standard curve with each
assay (Supplementary Fig. 4a). Notably, there was no difference
between Sis1-WT and LGMDD1 mutants stimulized Ssa1 ATP hydrolysis rate in the absence of any client protein (Supplementary Fig. 4b)
or in the presence of Rnq1 monomer (Supplementary Fig. 4c). This
may be due to the fact that “denatured monomer” presents a variety
of epitopes that can be recognized by chaperone whereas the
ﬁbers likely have fewer sites for recognition. However, the stimulation of Ssa1 ATP hydrolysis rate was signiﬁcantly reduced with the
mutants in the presence of Rnq1 seeds formed at 18, 25, and 37 °C
(Fig. 3a–c). Taken together, these data suggest that the different
Rnq1 conformers afford differences in Sis1-mediated Hsp70
ATPase stimulation and the LGMDD1 mutants all show functional
deﬁciencies.
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The initial step in this chaperone cycle relies on the ability of Hsp40 to
bind to client. Thus, we wanted to test the physical and functional
interactions of LGMDD1 mutants with our Rnq1 and luciferase substrates. We performed a binding assay utilizing a method previously
used to study interactions between the E. coli DnaJ and substrates30.
We found that LGMDD1 mutants show signiﬁcantly reduced binding to
denatured Rnq1 (similar substrate used for Supplementary Fig. 4c) and
luciferase substrates as compared to Sis1-WT (Fig. 4a, b) at low concentrations of substrate.
A key function for Hsp40s is stimulating Hsp70s. Our previous
work, suggests that the deleterious effect of the DNAJB6 G/F domain
mutants is Hsp70-dependent31. Thus, the LGMDD1 mutants might be
altered in their productive association with Hsp70. These mutants may
affect the cycle by either reducing Hsp70 binding, sequestering Hsp70,
or they may be hyperactive and alter the refolding process. Therefore,
we performed binding assays to determine whether there was a productive association between the LGMDD1 mutants and Ssa1. We found
that the interaction between LGMDD1 mutants and Ssa1 was signiﬁcantly reduced both in the absence (Fig. 4c) and presence of client
proteins Rnq1 (Fig. 4d) and luciferase (Supplementary Fig. 5). This
indicates that the reduced interaction between the mutants and Ssa1 is
client-independent. Thus, the decrease in Hsp70 ATPase activity with
LGMDD1 mutants (Fig. 3a–c) could, at least in part, be due to reduced
Hsp70 binding.

LGMDD1 G/F domain mutants show reduced dimerization
efﬁciency
Most of the canonical class I and class II J-proteins exist as
oligomers13. The efﬁcient function of Sis1 requires the ability of the
5
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Fig. 4 | Sis1 binding to both substrate and Hsp70 is compromised in the presence of LGMDD1 G/F domain mutants. Binding of puriﬁed Sis1-WT (black), Sis1F106L (yellow), Sis1-N108L (red), Sis1-D110Δ (green), or Sis1-F115I (blue) to denatured Rnq1 a and luciferase b. Rnq1 (400 ng) and luciferase (100 ng) were immobilized in microtiter plate wells and dilutions of puriﬁed Sis1-WT and Sis1-mutants
(0, 1, 3, 5, 8, 10, 20, 25, and 50 nM) were incubated with each substrate. The amount
of Sis1 retained in the wells after extensive washings was detected using a
Sis1 speciﬁc antibody. For c; Ssa1 (200 nM) was immobilized in microtiter plate
wells and dilutions (0, 1, 3, 5, 8, 10, 20, 25, and 50 nM) of puriﬁed Sis1-WT (black),
and Sis1-mutants (Sis1-F106L (yellow), Sis1-N108L (red), Sis1-D110Δ (green), or Sis1-

F115I (blue)) or BSA (brown) as a control, were incubated with it. Bound Sis1 was
detected using an αSis1 antibody. d Denatured Rnq1 were premixed with Sis1-WT/
mutants and immobilized in microtiter plate wells and dilutions of Ssa1-WT
(0–100 nM) were incubated with it. Bound Ssa1-WT was detected using an αSsa1
antibody. Only Ssa1 (cyan blue) was used as a control for d. Data represented as
mean values ± SEM, n = 3 biologically independent samples. For a–d, Sis1-WT was
compared to LGMDD1 mutants and ***p < 0.001 values are reported for unpaired,
two-sided t-test. RFU stands for Relative ﬂuorescence unit. Source data are provided as a Source data ﬁle.

Fig. 5 | LGMDD1 G/F domain mutants showed reduced dimerization. a For
homodimerization, uncleaved His-tagged Sis1-WT and mutants (20 nM) were
added into non-His-tagged (cleaved) Sis1-WT and mutants (200 nM) and adsorbed
in microtiter plate wells. b For heterodimerization, uncleaved His-tagged Sis1-WT
(20 nM) was added to cleaved mutants (200 nM) and adsorbed in microtiter plate
wells. In both a, b, following adsorption, ELISA was performed using an anti-His

antibody. Values shown are mean + SEM, n = 3 biologically independent samples.
For a, b; all LGMDD1 mutants were compared with Sis1-WT; for F106L
(***p < 0.0008 and **p < 0.003), for N108L (**p < 0.008 and **p < 0.004), for D110Δ
(***p < 0.0006 and **p < 0.005), and for F115I (***p < 0.0009 and **p < 0.006) values
are reported for unpaired, two-sided t-test. Source data are provided as a Source
data ﬁle.

protein to form dimers. In fact, Sis1 (1–337aa), which lacks the
dimerization motif (Sis1-ΔDD), exhibited severe defects in chaperone
activity, but could regulate Hsp70 ATPase activity32. Sha et al. proposed that the Sis1 cleft formed in dimers functions as a docking site
for the Hsp70 peptide-binding domain and that this interaction
facilitates the transfer of peptides from Sis1 to Hsp7033. Thus,
in order to further evaluate the chaperone activity of the these
mutants, we set out to measure their dimerization efﬁciency. We

performed binding assays to determine the relative competence of
both the self-association of the mutants as well as their association
with Sis1-WT. We found that there was a signiﬁcant decrease in selfassociation of all the mutants as compared to Sis1-WT (Fig. 5a). Sis1WT lacking the dimerization domain (Sis1-ΔDD) was used a
control and showed reduced dimerization as compared to Sis1-WT
(Supplementary Fig. 6). We also found that their ability to bind to
Sis1-WT was signiﬁcantly reduced (Fig. 5b), indicating a possible
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Fig. 6 | LGMDD1 G/F domain mutants inhibit Sis1-WT induced ATPase activity
of Ssa1. Stimulation of Ssa1 ATPase activity in the presence of Rnq1 seeds formed at
18 °C. Sis1-mutants (Sis1-F106L a, or Sis1-F115I b) (0–0.08 µM) were titrated with
Sis1-WT (0.03 µM) in the presence of Ssa1 (1 µM) and ATP (1 mM). The fraction of
ATP converted to ADP was determined at 30 min. Data represented as mean ± SEM,
n = 3 biologically independent samples. For a, b; values of the increasing

concentration of LGMDD1 mutants (0.01–0.08 µM) were compared with Sis1-WT
(0.03 µM) alone. For a (top to bottom); *p < 0.049, **p < 0.001, ***p < 0.0008,
***p < 0.0001, ***p < 0.0003, ***p < 2.18e−05, ***p < 2.62e−06. For b (top to bottom);
**p < 0.007, *p < 0.012, *p < 0.01, ***p < 0.0008, ***p < 0.0001, ***p < 6.4e−05,
***p < 2.11e−05. p-values are reported for unpaired, two-sided t-test. Source data are
provided as a Source data ﬁle.

explanation for the reduction in chaperone activity observed with
these mutants.

used two established biochemical yeast prion assays that differentiate soluble and aggregated protein: well-trap and boiled gel
assays. We found that the deletion of Sse1 partially rescues [RNQ+]
prion propagation (Fig. 7a, b and Supplementary Fig. 9a). However, it
was speciﬁc to Sse1, as the alteration of the other NEFs did not
demonstrate such rescuing (Supplementary Fig. 9b). This was not
surprising, as Sse1 is the principal NEF in yeast and performs 90% of
the NEF activity in the cell36.
In order to conﬁrm that deletion of Sse1 does improve the [RNQ+]
prion propagation, we assessed the effect of a well characterized Sse1
mutant, (Sse1-G233D). This mutation eliminates ATP binding by Sse1,
and therefore binding to Ssa1, nearly completely. It therefore delays
release of ATP from Ssa1 but only because it never binds Ssa1, and is
essentially identical to strains lacking Sse137. We performed boiled gel
assays to examine the relative levels of soluble Rnq1 prion protein in
[RNQ+] cells. Indeed, we found a decrease in soluble Rnq1 protein in
LGMDD1 cells expressing Sse1-G233D (Supplementary Fig. 9c). This
indicates restoration of [RNQ+] prion propagation in LGMDD1 mutants
with NEF modulation.
To further understand the impact of Sse1 on the LGMDD1 diseaseassociated mutants, we assessed the refolding of a non-prion substrate
(ﬁreﬂy luciferase; FFL). We utilized an in vivo refolding assay in which
FFL is denatured in cells by heat shock and its subsequent refolding,
which requires the Hsp40/Hsp70/Hsp104 chaperone machinery, is
measured by activity38,39. We transformed the Sse1 and Δsse1 yeast cells
carrying Sis1-WT, LGMDD1 mutants, and Sse1-G233D with GPD-lux
vector for the expression of FFL. Since Hsp104 is required for efﬁcient
refolding of FFL, we used a Δhsp104 strain expressing FFL as a negative
control. We found that the FFL refolding activity was signiﬁcantly
altered in Sse1 cells expressing F115I as compared to cells expressing
Sis1-WT (Fig. 7c). This difference in FFL refolding activity between
LGMDD1 mutants (F115I) and Sis1-WT was non-existent in Δsse1 yeast
cells (Fig. 7c). However, we observed that the FFL refolding activity was
marginally higher in Δsse1 yeast cells expressing F115I as compared to
Sse1-WT cells expressing the same mutant protein (Fig. 7c). Interestingly, Δsse1 yeast cells co-expressing F115I and Sse1-G233D showed
signiﬁcant improvement in FFL refolding activity as compared to Sse1WT yeast cells (Fig. 7c). Taken together, our results indicate that
LGMDD1 mutants delay Hsp70 ATPase activity, possibly resulting in
the increased load of aggregation-prone muscular proteins observed
in LGMDD1 patients.

LGMDD1 G/F domain mutants inhibit Sis1-WT induced Ssa1
ATPase activity by reducing its dimerization and substrate
binding efﬁciency
Since LGMDD1 has been described as an autosomal dominant disease,
we set out to test the effect of LGMDD1 mutants on the Sis1-WT in
functional assays. We performed ATPase assays with mixtures of Sis1WT and LGMDD1 mutants F106L and F115I in the presence of Rnq1
ﬁbers formed at 18 and 25 °C. We found a gradual decrease in the rate
of ATP hydrolysis that correlated with titrating Sis1-WT with F106L
(Fig. 6a and Supplementary Fig. 7a) and F115I (Fig. 6b and Supplementary Fig. 7b).
Next, we wanted to determine whether the mutants also inhibit
the ability of wild-type protein to dimerize. We found that there was a
concomitant decrease in dimerization of Sis1-WT with the addition of
F106L (Supplementary Fig. 8a) and F115I (Supplementary Fig. 8b). We
then asked whether the mutants also inhibit the ability of wild-type
protein to bind substrates efﬁciently. The binding efﬁciency to Rnq1
(Supplementary Fig. 8c) and luciferase (Supplementary Fig. 8d) substrates were slightly but signiﬁcantly reduced when Sis1-WT was used
in equal proportion (1:1) with each of the LGMDD1 mutants F106L and
F115I. These data provide mechanistic insight into the inhibition of Sis1WT-induced Ssa1 ATPase activity in the presence of LGMDD1
mutants (Fig. 6).

7. Modulating Hsp40-Hsp70 cycle by either deleting or inhibiting nucleotide exchange factors (NEFs) can be beneﬁcial with
respect to LGMDD1 G/F mutant effect in vivo
The lifetime of the Hsp70/40:substrate complex is dependent upon
nucleotide exchange. A key player in this is nucleotide exchange
factors (NEFs) that stimulate ADP release. In yeast, cytosolic Hsp70
interacts with three NEFs homologous to human counterparts: Sse1/
Sse2 (Hsp110), Fes1 (HspBP1), and Snl1 (Bag-1)34,35. Previously, we
found that LGMDD1 mutants impair viability and prion propagation
in yeast and these effects were rescued by reducing the association
with Hsp7031. Thus, we decided to investigate whether deleting
Hsp110 (Sse1) would have a similar rescuing effect. To assess the
impact of NEFs, we asked whether their deletion would enhance the
ability of LGMDD1 mutants to propagate [RNQ+] prion strains. We
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Fig. 7 | Deletion or inhibition of Sse1 function rescues prion propagation of
[RNQ+] and restored impaired FFL refolding. a, b Deletion of Sse1 partially suppresses prion loss caused by LGMDD1 mutants. Analysis of prion propagation in
Sse1 and Δsse1 strains harboring s. d. medium [RNQ+], expressing either Sis1-WT or
Sis1-F115I or Sis1-F106L by well-trap assay. Cell lysates were incubated at room
temperature (−) or 100 °C and subjected to SDS-PAGE and western blot using an
αRnq1 antibody. Rnq1 that is not sequestered in aggregates will enter the gel in the
unboiled sample, which indicates destabilization of the [RNQ+] prion. The western
blotting was done in triplicate and representative image is shown here. For a, b; the
lines above the bars shows the samples which were compared and **p < 0.01,

*p < 0.05, NS (non-signiﬁcant) values are reported for unpaired, two-sided t-test.
c The refolding of ﬁreﬂy luciferase (FFL) was measured in the Sse1 and Δsse1 yeast
cells carrying Sis1-WT, LGMDD1 mutant (Sis1-F115I), and Sse1 mutant (Sse1-G233D)
along with a plasmid expressing FFL. Yeast were normalized, treated with cycloheximide, and subjected to heat shock at 42 °C for 22 min, followed by recovery at
30 °C. Luminescence was measured at the indicated time points during recovery.
Values shown are mean + SEM, n = 9 biologically independent samples. The table
shows the samples that were compared at each time points. ***p < 0.001, **p < 0.01,
*p < 0.05, NS (non-signiﬁcant) values are reported for unpaired, two-sided t-test.
Source data are provided as a Source data ﬁle.

Discussion

worse without client) (Fig. 4c). The mutants showed similar reduction
in Hsp70 ATPase stimulation, but it was client conformation-dependent, as expected based on previous work12 (Fig. 3a–c and Supplementary Fig. 4c). Finally, the mutants showed similar reduction in
luciferase refolding efﬁciency (Fig. 1c).
We also took advantage of the yeast prion model system and its
unique conformer:phenotype read-out. Prion proteins can form
several unique prion variants (or strains) that have slight differences
in their β-sheet structure that constitute distinct amyloid
conformations41. Such different structures are presumably the
underlying cause of the diverse phenotypic variation seen in both
yeast and prion diseases20. Several mammalian pathological proteins
have also been shown to adopt distinct self-propagating aggregates
or “strains” with different structures, which are presumably linked to
the phenotype diversities of degenerative diseases16,42–44. One such
example is Tau protein, deposition of whose pathological forms
results into Tauopathies, which includes Alzheimer’s disease, FrontoTemporal Dementia (FTD). Several studies support the “tau strain

Proper functioning of protein chaperones, including that of Hsp70/
DNAJ, is important for the maintenance of muscle function40 (Supplementary Fig. 10). Previously, we have shown that the LGMDD1
mutations in the G/F domain of DNAJB6 disrupt client processing in
both a substrate- and conformation-speciﬁc manner12. Here, we delved
into the mechanism underlying the defect in client processing shown
by LGMDD1 G/F domain mutants. Our data show that the LGMDD1
mutants ability to stimulate Hsp70 ATPase activity was reduced as
compared to the wild-type protein (Fig. 8a), which may result in general impairment of protein quality control and accumulation of protein
inclusions in muscle. Analyzing the severity of the mutants, we ﬁnd a
signiﬁcant difference in many steps in the Hsp40/70- cycle. No aspect
of its functionality is unaffected by these disease causing G/F domain
mutants (Fig. 8a). All mutants showed decreased binding to substrate
(Fig. 4a, b), with D110Δ = F106L < F115 = N108L. Mutants also impact
dimerization similarly with D110Δ = F106L < N108L = F115I (Fig. 5). The
LGMDD1 mutants showed similar binding defects to Hsp70 (D110Δ
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Fig. 8 | Schematic diagram depicting possible mechanism of LGMDD1 mutants
and their effects on the Hsp70 ATPase cycle, as well as proposed therapeutic
intervention. a Cartoon depicting possible mechanistic insights as to how
LGMDD1 G/F domain mutants delay or inhibit the Hsp70 ATPase cycle. The dashed
red arrows indicate inhibition. Mutants were inefﬁcient in terms of both homo and
hetero-dimerization and that may be related to their reduced ability to assist Hsp70
in protein folding. In the ﬁrst half of the Hsp70 ATPase cycle, LGMDD1 mutants
were incompetent in their ability to bind speciﬁc substrate conformers and Hsp70
(black dashed arrows), which delays the downstream processing of the substrate

through Hsp70-ATPase cycle. This inhibition could negatively impact Hsp70mediated ATP-hydrolysis. b Possible therapeutic route. In the second half of the
cycle, modulation of NEF inhibit the binding and exchange of nucleotide, which
delay the downstream process of substrate release in the cycle. However, this delay
led to positive consequences in terms of yeast prion propagation (green arrow
represents restoration of normal function). Thus, altering the balance between the
two halves of the Hsp70-ATPase cycle may provide one route for therapeutic
intervention for these types of diseases.

hypothesis”, which proposes that different aggregated tau conformers (distinct strains) have distinct pathology-initiating capacities
because they interact with endogenous tau differently45,46. In yeast,
the interaction between the prion protein Rnq1 and the Hsp40 Sis1 is
required for [RNQ+] propagation29. Therefore, we utilized this system
to ask whether the LGMDD1 mutants impacted the [RNQ+] prion
strains that form de novo. Strikingly, we found a change in [RNQ+]
prion strain formation when Rnq1 ﬁbers were formed in the presence
of the LGMDD1 mutants as compared to wild type Sis1. These changes were a direct consequence of Hsp40 interaction alone and may
be a consequence of DNAJ proteins ability to act as “holdases”47,48.
“Holdases” are chaperones that do not use ATP and simply protect
their client protein from aggregation48. Unlike “holdases”, “foldases”
(like Hsp70) accelerate the transition of non-native conformations
towards native states in an ATP-dependent manner. Interestingly, the
proteostasis network relies on a constant interplay between these
two kinds of chaperones. Putative “holdase” activity is not shown in
the Hsp40/70-cycle and may well be altered with the LGMDD1
mutants (Supplementary Fig. 10).
As a major role for Hsp40s is stimulating Hsp70s, another
important aspect of the LGMDD1 mutants might be a change in the
productive interaction with Hsp7025. Indeed, we found that these
LGMDD1 mutants were defective in binding to Ssa1 (Hsp70) as well as
to substrates (Rnq1 and luciferase). It had been shown previously that
there was no difference between Sis1-WT and the Sis1-G/F domain
knockout induced Ssa1 ATPase activity in absence of substrate25.
Interestingly, however, the LGMDD1 mutants showed a reduction in
the stimulation of ATPase activity of Hsp70. Moreover, in the presence
of substrate, the change in ATPase activity was client-conformer speciﬁc. Additionally, LGMDD1 mutants were defective in refolding heat-

denatured luciferase (similar to previous ﬁndings with Sis1ΔG/F25),
indicating a more global defect in substrate remodeling. These ﬁndings ﬁt with recent data that implicate the G/F-rich region of DNAJB1 in
an autoinhibitory mechanism that regulates the major class B J-domain
proteins (JDPs)49. This inhibition can be released with second site
mutations (E50A, or F102A, and or ΔH5) in DNAJB149. A similar
mechanism has been suggested for both DNAJB6 and DNAJB8
proteins50,51. Our data suggest that the LGMDD1 G/F domain mutants
are not simply releasing the auto-inhibitory mechanism, however, as
they show reduced binding to Hsp70 in the absence of client, indicating that the complex (Sis1-substrate-Hsp70) formed with Hsp70 is
indeed driven by the Sis1-substrate interaction.
The function and interaction of the various Hsp40 domains have
been studied extensively13,52. The efﬁciency of Hsp70 ATPase activity is
heavily dependent on the proper functioning of the J and G/F domains
of Hsp4052,53. Moreover, Hsp40 (Sis1) functions as a dimeric protein32.
Interestingly, we found that LGMDD1 mutants show a diminished
ability to form homodimers and heterodimers (with Sis1-WT). However, DNAJB6 has not been described as a dimer (and is instead polydispersed) and has a CTD that is distinct from that of Sis1-WT or
DNAJB1. Thus, the decreased dimerization efﬁciency observed with the
homologous mutants in Sis1 just provides further insight into other
possible changes with DNAJB6 G/F domain mutants.
Previously, it was suggested that the LGMDD1-causing mutations
exert a deleterious dominant negative effect on the wild-type protein3.
An excess of mutant (DNAJB6-F93L) to wild-type mRNA induced lethality in embryos, while an excess of wild-type to mutant mRNA gave
rise to progressively increased rescue3. Consistent with this, we found
that titrating Sis1-WT with LGMDD1 mutants (F106L and F115I)
decreased Ssa1 ATPase activity.
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Interaction of the Hsp70/40 machinery with a misfolded client is
not sufﬁcient to promote re-folding. The regulated cycle of client
release and the potential for re-engagement is important, and this is
dependent on nucleotide exchange. Indeed, changes in the availability
or function of nucleotide exchange factors (NEFs) alone change client
processing. Alterations in the NEF Sse1 were shown to alter yeast prion
propagation in a strain-dependent manner54. Sse1 has been proposed
to have multiple functions and can act as a disaggregase itself55,56. Our
data suggest that the effect of the LGMDD1 mutants on the propagation of the [RNQ+] strain can be rescued by the deletion of Sse1
(Hsp110). Notably, although the deletion of Sse1 alone showed partial
improvement in [RNQ+] prion propagation in yeast cells, it did not
show any difference in the refolding of luciferase, again perhaps
indicating substrate speciﬁcity. This indicates that for some clients,
these mutants might be rescued by modulating the time of interaction
with Hsp70/40.
We hypothesize that the observed defects in the LGMDD1
mutants result in cellular phenotypes that are client-conformer
speciﬁc. The Hsp70/DNAJ ATPase cycle is a process partitioned into
two interconnected events; DNAJ is vital in the ﬁrst half whereas NEFs
play a signiﬁcant role in the second half. Our data suggest that there
are numerous defects associated with DNAJB6 (Sis1) mutants which
result in either inhibition or delay in client processing in the ﬁrst part
of the Hsp70-ATPase cycle. Hsp70 has been shown to suppress
proper substrate folding if it is not allowed to cycle off its client
protein in various contexts57,58. Henceforth a longer interaction of
LGMDD1 mutants with Hsp70 might lead to broader disruption of
Hsp70-dependent processes, as this could titrate Hsp70 away from
other clients59. Our data suggest that inhibiting the second half of the
ATPase cycle, can have positive consequences on client processing.
Interestingly, previous data suggest that the optimal NEF activity for
protein disaggregation occurs at a reduced ratio of NEF:Hsp70
(1:10)60–62, and perhaps the deletion of Sse1 recapitulates such
reduction in NEF activity in some manner (such as replacing the
optimal NEF with another, such as Fes1). Moreover, the armadillotype NEFs (budding yeast Fes1 and its human homolog HspBP1)
employ ﬂexible N-terminal release domains (RDs) with substratemimicking properties to ensure the efﬁcient release of persistent
substrates from Hsp7063. This is plausible due to the fact that NEFs
perform dual functions: accelerating nucleotide exchange and
securing Hsp70-liberated substrates. Of note, the high selectivity of
exchange factors for their Hsp70 partner contributes to the functional heterogeneity of Hsp70 chaperone system64. These results
indicate that ﬁne-tuning of the two halves of the Hsp70 ATPase cycle
involving LGMDD1 mutants and NEFs during the processing of its
client proteins is critical (Fig. 8b). As such, we suggest that NEF
inhibitors could provide a possible therapeutic strategy for the
treatment of LGMDD1. There are certain aspects of DNAJB6 activity
which are imperfectly modeled by Sis1. Nevertheless, in the absence
of a clear mammalian substrate for DNAJB6, these ﬁndings with its
closest yeast homolog Sis1 and the impact of the LGMDD1 mutants
on client processing provide crucial mechanistic insight to begin to
explore therapeutic routes for this myopathy.

Method
Cloning, expression and puriﬁcation of recombinant proteins
Sis1-WT, Sis1-mutants (F106L/N108L/D110Δ/F115I/ΔDD) and Ssa1-WT
were cloned into pPROEx-Htb vector obtained from Addgene. The
plasmid encodes a hexa-His-tag, a TEV cleavage site, and the
respective cloned gene for expression. All Sis1 mutants were generated using the Quick Change Mutagenesis Kit (Agilent Technologies
#200517). Primer sequences were generated using Agilent’s online
primer design program. Mutagenesis was conﬁrmed by sequencing
the entire coding region of Sis1. Sis1-WT and Sis1-mutants were
expressed at 16 °C, whereas Ssa1-WT was expressed at 18 °C to
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increase the fraction of soluble protein. All puriﬁcation steps were
carried out at 4 °C. Protein purity was more than 99% as determined
by SDS/PAGE and Coomassie staining. Final protein concentration
was estimated by Bradford assay, using bovine serum albumin as the
standard. Following puriﬁcation, all the proteins were frozen on
liquid nitrogen and stored at −80 °C till further use. Sis1-WT and
mutants were puriﬁed using standard protocol with some modiﬁcations. Brieﬂy, these were puriﬁed from Escherichia coli strain Lemo
21(DE3) (New England Biolabs #C2528H) grown in 2X YT medium at
30 °C until OD600 = 0.6–0.8. The cultures were induced with 0.5 mM
IPTG and grown overnight at 16 °C. Cells were harvested and lysed in
buffer A (50 mM Sodium phosphate buffer (pH 7.4), 300 mM NaCl,
5 mM MgCl2, 10 mM Immidazole, 0.1% Igepal, 0.01 M TCEP (tris(2carboxyethyl)phosphine) (Thermo-Fisher Scientiﬁc #20491), protease inhibitor cocktail (EDTA-free) (Thermo-Fisher Scientiﬁc
#A32965) and a pinch of DNase I (Millipore Sigma #DN25). Cell debris
was cleared by centrifugation (20,000 × g) and the supernatant loaded on cobalt-based Talon metal afﬁnity resin (Thermo-Fisher Scientiﬁc #89964). After washing, proteins were eluted as gradient
fractions with buffer A containing increasing concentrations of imidazole (150–400 mM) (Millipore Sigma #I0125). Puriﬁed proteins
were incubated with His-TEV (puriﬁed in the lab) protease at 30° for
1 h. The samples were extensively dialyzed at 4 °C and again passed
through Talon metal afﬁnity resin to remove the cleaved His tag and
His-TEV protease. The pure proteins were concentrated and stored at
−80 °C. Similarly, Ssa1-WT protein was also puriﬁed using an established procedure65. Brieﬂy, protein was puriﬁed from Escherichia coli
strain Rosetta 2(DE3) (Novagen, EMD-millipore #71397-3) grown in
LB medium with 300 mM NaCl at 30 °C until OD600 = 0.6–0.8. The
culture was induced with 0.5 mM IPTG and grown overnight at 18 °C.
Cells were harvested and lysed in buffer A (20 mM Hepes, 150 mM
NaCl, 20 mM MgCl2, 20 mM KCl, protease inhibitor cocktail (EDTAfree) using lysozyme (Millipore Sigma #L6873). The rest of the protocol was similar to that of Sis1-WT and mutants, with only exception
being that Ssa1-WT was eluted with buffer A containing 250 mM
imidazole. Rnq1-WT full-length protein was puriﬁed exactly as
described in previous publication from our lab26.

Binding assays
Substrate-binding ELISA assays. This was performed as described
earlier25 with some modiﬁcations. Two different substrate proteinsRnq1 and ﬁreﬂy luciferase (Millipore Sigma #SRE0045) were denatured
for 1 h at 25 °C in a buffer comprising of 3 M guanidine HCl, 25 mM
HEPES (pH 7.5), 50 mM KCl, 5 mM MgCl2, and 5 mM DTT. Following
denaturation, substrates were diluted in 0.1 M NaHCO3 and bound to
microtiter plate (CoStar 3590 EIA plates, Corning #CLS3590) at a
concentration of 0.4 µg/well for Rnq1 and 0.1 µg/well for luciferase,
respectively. Unbound substrate was removed by washing with phosphate buffered saline (PBS). Unreacted sites were blocked with 0.2 M
glycine (100 µl/well) for 30 min at 24 °C, followed by washing with PBST (PBS containing 0.05% Tween 20). Non-speciﬁc binding was eliminated by blocking with 0.5% fatty-acid-free bovine serum albumin
(BSA) (Millipore Sigma #A6003) in PBS for 6 h. The wells were subsequently washed with PBS-T. Sis1-WT and Sis1-mutants were serially
diluted in PBS-T (substituted with 0.5% BSA) and incubated with substrate for overnight at 24 °C. After extensive washing with PBS-T, rabbit
anti-Sis1 antibody (CosmoBio #COP-080051) at a dilution of (1:15000)
was added and incubated for 2 h at 24 °C. This was followed by further
washings and the addition of donkey-anti-rabbit HRP-conjugated
(1:4000) (Millipore Sigma #AP182P) as secondary antibody. The
amount of Sis1 retained was determined by developing a reaction
using tetramethyl benzidine/H2O2 (TMB peroxidase EIA substrate) kit
(Bio-Rad #1721068)). The color was measured at 450 nm (SpectraMax
M2e ﬂuorimeter microplate reader) after terminating the reaction with
0.02 N H2SO4.
10
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Ssa1-binding assays. Ssa1 (200 nM) was immobilized in microtiter
plate wells and dilutions of puriﬁed Sis1-WT and Sis1-mutants were
incubated with it. Bound Sis1 was detected as described above.
Substrate bound Sis1 combined with Ssa1 binding assays. Denatured substrates (Rnq1 and luciferase) at a concentration of 0.4 μg/well
and 0.1 ug/well, respectively, were mixed with Sis1-WT and Sis-mutant
proteins (5 nM) and incubated for 1 h at 24 °C, prior to being adsorbed
in the microtiter well plates. Following the steps of incubations,
washings and blocking, serially diluted Ssa1-WT was added to each
well. Subsequently, the wells were probed with mouse-Hsp70 (Ssa1)
antibody (1:2000) (Abcam #ab-5439), followed by goat anti-mouse IgG
[H + L] HRP conjugated secondary antibody (1:4000) (Thermo-Fisher
Scientiﬁc #62-6520). The detection method used was similar to that
described above for detecting Sis1.
Homo/Hetero dimeric nature of Sis1 determining binding assays.
Serially diluted His-tagged cleaved Sis1-WT and Sis1-mutants were
adsorbed in the microtiter well plates. Following washings, serially
diluted uncleaved His-tagged Sis1-WT and Sis1-mutants were added to
the wells in the following combinations [(Cleaved mutants + Uncleaved
mutants = Homodimer); (Cleaved mutants + Uncleaved Sis1-WT =
Heterodimer) along with appropriate controls for the assay. This was
followed by washings, blocking and addition of mouse anti-His antibody (1:5000) (Novagen #37-2900). Rabbit anti-mouse HRP conjugated antiserum (1:4000) (Millipore Sigma #AP160P) was used as
secondary antibody. The detection method was similar to that
described above.
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absorbance to account for intrinsic ATP hydrolysis. To account for
variability in measurements a phosphate standard curve (using
potassium phosphate) was created for each day of measurements. For
ATPase activity in presence of client proteins, the same procedure was
followed with only exception being the addition of client protein Rnq1
monomer (25 µM) and Rnq1 seeds (10% of which is used in ﬁnal reaction) formed at three different temperatures (18, 25, and 37 °C) with
the chaperones and ATP for incubation.

Luciferase refolding assay
Heat denatured refolding of luciferase was performed as previously
described67. Brieﬂy, Ssa1 (2 µM) were incubated in refolding buffer
(50 mM Tris pH 7.4, 150 mM KCl, 5 mM MgCl2) supplemented with
1 mM ATP and an ATP regenerating system (10 mM phosphocreatine,
100 mg/ml phosphocreatine kinase) for 15 min at room temperature.
Next, luciferase (25 nM) was added and incubated for a further 10 min.
Then Sis1-WT/mutants (0.05 µM) was added and the mixture was heat
shocked at 44 °C for 20 min. The reactions were then immediately
moved to room temperature. Finally, 25 µL aliquots of the refolding
reaction were then taken and added to 50 µL of luciferase assay reagent
(Promega Corporation #E1501). At various time points, activity was
then measured with a GloMax Luminometer (Promega Corporation).

Titration assays
All the assays were performed by titrating the concentration of Sis1mutants (F106L and F115I) with Sis1-WT (concentration been kept
constant).

Yeast strains, plasmids and Transformation
Amyloid ﬁber formation and thioﬂavin T kinetics
Puriﬁed Rnq1 was resuspended in 7 M guanidine hydrochloride (Millipore Sigma #G3272) and the protein concentration was determined.
Rnq1 ﬁbers were formed at 18, 25, and 37 °C with a starting monomer
concentration of 8 μm in Fiber-formation buffer (FFB) (50 mM KPO4,
2 M Urea, 150 mM NaCl, pH 6). For the seeded kinetics experiments,
the ﬁbers were seeded using 5% (w/w) seed. The ﬁber formation and
kinetics assays were performed in the presence of Thioﬂavin T dye
(Millipore Sigma #T3516) and acid-washed glass beads (Millipore
Sigma #G8772) for agitation as described earlier26. Kinetic assays of
ﬁber formation were done in a SpectraMax M2e ﬂuorimeter microplate
reader. The change in Thioﬂavin-T ﬂuorescence over time was measured using an excitation wavelength of 450 nm and emission wavelength of 481 nm.

Colorimetric determination of ATPase activity
The ATPase assay was performed as described before66 with some
modiﬁcations. Brieﬂy, the ATPase reagent was made by combining
0.081% W/V Malachite Green (#M6880) with 2.3% W/V poly-vinyl
alcohol (#363138), 5.7% W/V ammonium heptamolybdate (#09878) in
6 M HCl (#258148), and water in 2:1:1:2 ratios (all purchased from
Millipore Sigma with no further puriﬁcation). This ATPase reagent was
freshly prepared every day and was left standing for 2 h to get a stable
green/golden solution, which was ﬁltered through 0.45 μm syringe
ﬁlters (Millipore Sigma #SLHA033SS) before use. ATPase activity in the
absence of any client protein was tested by incubating Sis1-WT/
mutants, Ssa1-WT in the ratio of (0.05:1.0 µM) with 1 mM ATP, in assay
buffer (0.02% Triton X-100, 40 mM Tris–HCl, 175 mM NaCl, and 5 mM
MgCl2, pH 7.5) at 37 °C for different time-intervals as indicated in the
ﬁgure legends. At the end of incubation 25 µL of the reaction was
added to a well in a 96 well plate, followed by 800 µL of the ATPase
reagent and 100 µL of 34% sodium citrate to halt any further ATP
hydrolysis. The mixture was allowed to incubate for 30 min at 24 °C
before absorbance at 620 nm was measured using a SpectraMax M2e
ﬂuorimeter microplate reader. A sample of ATP alone in buffer was
treated exactly the same and was subtracted from the sample
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The yeast strains used in this study are derived from Saccharomyces
cerevisiae 74-D694 (ade1-14 his3-Δ200 leu2-3, 112 trp1-289 ura 3-52).
Yeast cells were grown and manipulated using standard techniques68.
As indicated, cells were grown in rich media YPD (1% yeast extract, 2%
peptone, 2% dextrose) or in synthetic deﬁned (SD) media (0.67% yeast
nitrogen base without amino acids, 2% dextrose) lacking speciﬁc
nutrients to select for appropriate plasmids. Wild-type (WT) yeast
harboring the s. d. medium [RNQ+] variant and the [rnq-] control strain
were kindly provided by Dr. Susan Liebman (University of Nevada,
Reno, Nevada, USA)69. Construction of Δsis1 [rnq-] and s. d. medium
[RNQ+] yeast strains were described previously12. Δsse1 was created
using a plasmid-based sse1Δ::LEU2 disruption construct (a kind gift
from Dr. Kevin Morano) that was digested with SacII/PstI and transformed into sis1Δ cells propagating s.d. medium [RNQ+] and expressing Sis1 from a URA3-marked plasmid. All other delta strains in s. d.
medium [RNQ+] background were created using the standard protocol. Medium containing 1 mg/mL 5-ﬂuoroorotic acid (5-FOA) that
selects against cells maintaining URA3- marked plasmids was used to
replace WT Sis1 with the mutant constructs using the plasmid shufﬂe
technique. Plasmid transformations were done using polyethyleneglycol/lithium-acetate (PEG/LioAC) technique, and the cells were
selected using SD-trp/his plates.
Plasmid pRS316-Sis1 was kindly provided by Dr. Elizabeth Craig
(University of Wisconsin, Madison, Madison, Wisconsin, USA)22. Plasmid pRS414-Sse1-G233D was a kind gift from Dr. Kevin Morano
(McGovern Medical School, UT Health, Houston, Texas, USA)37. Construction of pRS314-Sis1 and LGMDD1 mutants were described previously. Using the standard molecular techniques we constructed
p413TEF-Sse1-G233D. Plasmid pRS316-GPD-Lux was a kind gift from Dr.
Bernd Bukau (Center for Molecular Biology of Heidelberg University,
Heidelberg, Germany)39.

Protein ﬁber transformation for phenotypic analysis

Transformation of Rnq1 ﬁbers into a [rnq−] 74-D694 (ade1-14, ura3-52,
leu2-3,112, trp1-289, his3-200, sup35::RRP) yeast strain in the presence
and absence of Sis1-WT/ mutants was conducted as described70. The
11
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resulting colonies formed after infecting ﬁbers formed in vitro in the
presence and absence of chaperones were replica plated onto rich
medium (YPD) plates to assay for colony color. Colonies that appeared
to have acquired the prion state by nonsense suppression were picked
and spotted on YPD, YPD containing 3 mM GdnHCl, and SD-Ade for
phenotypic analyses.

https://doi.org/10.1038/s41467-022-32318-9

Data availability
The data that support this study are available from the corresponding
author upon reasonable request. Source data are provided with
this paper.
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